Loading...
Most of the thunder in the vaccine world this year belongs to the many promising candidates for COVID-19 control. Still, in its annual publication on vaccines for adults, the ACIP has made several adjustments to its 2020 recommendations for other vaccination protocols (NEJM JW Gen Med Mar 1 2020 and Ann Intern Med 2020; 172:337).
The most substantial changes in this year's document are the following:
As of July 2020, live zoster vaccine (Zostavax) is no longer available in the U.S.; recombinant vaccine (Shingrix) is the only option for zoster vaccination.
Live attenuated influenza vaccine (FluMist) can lose efficacy if it is administere…